We are live on
!
Find out more
BCM
Brown Capital Management Portfolio holdings
AUM
$500M
1-Year Est. Return
25.3%
This Fund
S&P 500
This Quarter
Est. Return
-22.92%
1 Year Est. Return
+25.3%
3 Year Est. Return
+79.24%
5 Year Est. Return
+57.49%
10 Year Est. Return
+614.96%
AUM
$7.47B
AUM Growth
-$2.58B
(-26%)
Cap. Flow
-$185M
Cap. Flow
% of AUM
-2.48%
Top 10 Holdings %
Top 10 Hldgs %
45.76%
Holding
129
New
2
Increased
25
Reduced
42
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xometry
XMTR
|
+$65.8M |
| 2 |
Repligen
RGEN
|
+$47.8M |
| 3 |
10x Genomics
TXG
|
+$39.8M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$38.9M |
| 5 |
CryoPort
CYRX
|
+$36.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PLAN
Anaplan, Inc.
PLAN
|
+$274M |
| 2 |
QuidelOrtho
QDEL
|
+$53.4M |
| 3 |
Neogen
NEOG
|
+$44.5M |
| 4 |
Veeva Systems
VEEV
|
+$33.9M |
| 5 |
ABMD
Abiomed Inc
ABMD
|
+$31.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 55.17% |
| 2 | Healthcare | 36.24% |
| 3 | Industrials | 6.94% |
| 4 | Materials | 0.75% |
| 5 | Consumer Discretionary | 0.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Manhattan Associates
MANH
$12.5B
| $395M | 5.28% |
3,443,836
-103,985
| -3% | -$12.9M |
|
|
2
Veeva Systems
VEEV
$44.5B
| $391M | 5.24% |
1,976,257
-184,089
| -9% | -$33.9M |
|
3
Tyler Technologies
TYL
$14.9B
| $378M | 5.06% |
1,135,593
-28,197
| -2% | -$10.3M |
|
4
Paycom
PAYC
$10.4B
| $374M | 5.01% |
1,335,273
-8,380
| -0.6% | -$2.47M |
|
5
Alarm.com
ALRM
$2.77B
| $359M | 4.81% |
5,802,689
-35,669
| -0.6% | -$2.19M |
|
6
Datadog
DDOG
$76.5B
| $320M | 4.29% |
3,361,954
+62,566
| +2% | +$6.88M |
|
|
ABMD
7
DELISTED
Abiomed Inc
ABMD
| $312M | 4.18% |
1,262,459
-116,346
| -8% | -$31.4M |
|
8
Cognex
CGNX
$10.5B
| $302M | 4.04% |
7,094,951
+157,548
| +2% | +$8.83M |
|
|
ANSS
9
DELISTED
Ansys
ANSS
| $295M | 3.95% |
1,233,723
+3,243
| +0.3% | +$858K |
|
10
Bio-Techne
TECH
$11.4B
| $291M | 3.9% |
3,358,348
-314,964
| -9% | -$29.5M |
|
11
AppFolio
APPF
$7.59B
| $287M | 3.85% |
3,170,021
-131,264
| -4% | -$13.2M |
|
|
12
Repligen
RGEN
$9.46B
| $285M | 3.82% |
1,757,047
+302,286
| +21% | +$47.8M |
|
|
SMAR
13
DELISTED
Smartsheet Inc.
SMAR
| $215M | 2.88% |
6,847,903
+18,528
| +0.3% | +$768K |
|
|
14
Neogen
NEOG
$2.58B
| $211M | 2.83% |
8,776,194
-1,658,006
| -16% | -$44.5M |
|
15
Guidewire Software
GWRE
$13.5B
| $202M | 2.71% |
2,849,627
-26,301
| -0.9% | -$2.15M |
|
16
Helios Technologies
HLIO
$2.36B
| $190M | 2.54% |
2,861,955
+121,839
| +4% | +$8.45M |
|
17
Q2 Holdings
QTWO
$3.87B
| $188M | 2.52% |
4,872,440
+96,267
| +2% | +$4.68M |
|
18
Vericel Corp
VCEL
$2.06B
| $185M | 2.48% |
7,347,887
+1,237,589
| +20% | +$36.5M |
|
|
19
QuidelOrtho
QDEL
$958M
| $177M | 2.37% |
1,821,001
-523,701
| -22% | -$53.4M |
|
20
OrthoPediatrics
KIDS
$585M
| $145M | 1.95% |
3,370,104
+8,042
| +0.2% | +$368K |
|
|
CYBR
21
DELISTED
CyberArk
CYBR
| $143M | 1.92% |
1,118,010
+6,335
| +0.6% | +$915K |
|
|
22
CryoPort
CYRX
$801M
| $140M | 1.87% |
4,507,634
+1,382,963
| +44% | +$36.8M |
|
|
PRO
23
DELISTED
PROS Holdings
PRO
| $137M | 1.84% |
5,230,298
-87,757
| -2% | -$2.48M |
|
24
Ironwood Pharmaceuticals
IRWD
$704M
| $134M | 1.8% |
11,641,935
-2,587,064
| -18% | -$30.5M |
|
25
Glaukos
GKOS
$10.5B
| $120M | 1.61% |
2,650,065
-219,351
| -8% | -$10.4M |
|
Similar funds
HC
TLP
ISWM
PT
FGWP
PCA
FNBOMD
TPWM
Brown Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Brown Capital Management held 129 positions worth $7.47B, down 26% from $10B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Brown Capital Management's Q2 2022 filing shows 2 new, 25 increased, 42 reduced and 5 closed positions. Its largest new stake was Xometry: 1,906,166 shares worth $64.7M. The largest sale was Anaplan, Inc., an estimated $274M.
By sector, the portfolio is most concentrated in Technology at 55% of assets, down from 58% a quarter earlier, followed by Healthcare and Industrials.
- Brown Capital Management's largest Q2 2022 buy was Xometry: 1,906,166 shares worth $64.7M.
- Brown Capital Management added most to Repligen in Q2 2022, an estimated $47.8M increase.
- Brown Capital Management's biggest Q2 2022 reduction was QuidelOrtho, cutting an estimated $53.4M.
- Brown Capital Management fully exited Anaplan, Inc. in Q2 2022, selling an estimated $274M.
- Brown Capital Management's ten largest holdings make up 46% of its $7.47B portfolio in Q2 2022.
- Brown Capital Management opened 2 new positions and closed 5 in Q2 2022.
- Brown Capital Management's portfolio value fell 26% quarter-over-quarter to $7.47B.
Based on Brown Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.